REQUEST A DEMO
Total
USD $0.00
Search more companies

Triclinic Barbara Chrzanowska sp. k. (Poland)

Main Activities: Ambulatory Health Care Services
Full name: Triclinic Barbara Chrzanowska sp. k. Profile Updated: February 01, 2022
Buy our report for this company USD 19.99 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Triclinic Barbara Chrzanowska sp. k. is a company in Poland, with a head office in Gdansk. The company operates in the Ambulatory Health Care Services sector. It was first established on January 24, 2022. In 2023, the company reported a net sales revenue increase of 51.13%. During that time, Triclinic Barbara Chrzanowska sp. k.’s total assets grew by 141.78%. Triclinic Barbara Chrzanowska sp. k.’s net profit margin decreased by 14.04% in 2023.

Headquarters
Ul. Belgradzka 73
Gdansk; Pomorskie; Postal Code: 80-288

Contact Details: Purchase the Triclinic Barbara Chrzanowska sp. k. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Triclinic Barbara Chrzanowska sp. k. report to view the information.
Incorporation Date:
January 24, 2022
Key Executives
Purchase this report to view the information.
Associate Partner
Purchase this report to view the information.
Limited Partner
Company Performance
Financial values in the chart are available after Triclinic Barbara Chrzanowska sp. k. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
51.13%
Total operating revenue
51.13%
Operating profit (EBIT)
13.69%
Net Profit (Loss) for the Period
13.63%
Total assets
141.78%
Total equity
110.81%
Operating Profit Margin (ROS)
-15.46%
Net Profit Margin
-14.04%
Return on Equity (ROE)
-44.96%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?